Salonpas Pain Relieving Jet

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with strains, sprains, bruises, simple backache, and arthritis.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and over should shake the can very well before use. To prevent frostbite, it is essential to hold the can approximately 4 inches (10 cm) away from the skin. Each affected area should be sprayed for no longer than 1 second. The application may be repeated on the affected area no more than 3 to 4 times daily.

For children under 12 years of age, it is recommended to consult a doctor prior to use.

Contraindications

Use of this product is contraindicated in the following situations:

• Application on wounds or damaged skin is prohibited due to the risk of exacerbating injury or infection.

• Concurrent use with a heating pad is not recommended, as it may lead to increased irritation or adverse effects.

• Individuals with known allergies to any ingredients in this product should refrain from use to prevent allergic reactions.

Additionally, caution is advised to avoid contact with the eyes, mucous membranes, or rashes, as this may result in irritation. Tight bandaging is discouraged to prevent compromised circulation, and inhalation of the product should be avoided to minimize respiratory irritation.

Patients should discontinue use and consult a healthcare professional if any of the following occur: skin reactions such as redness, itching, rash, excessive irritation, burning sensation, swelling, or blistering; worsening of conditions; persistence of symptoms beyond 7 days; or recurrence of symptoms after initial resolution within a few days.

Individuals with a history of allergic reactions to aspirin or salicylates should seek medical advice prior to use.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to consult a doctor prior to use if they have a history of allergic reactions to aspirin or salicylates.

This product is flammable; therefore, it is imperative to keep it away from fire or flame. It should not be used in areas where sparks may occur, nor in confined spaces. The container must not be punctured or incinerated, as it is under pressure. Additionally, exposure to temperatures exceeding 120 degrees F (48 degrees C) should be avoided.

The product should not be applied to wounds or damaged skin, nor should it be used in conjunction with a heating pad. Patients with known allergies to any ingredients in this formulation should refrain from use.

When utilizing this product, it is essential to follow the directions provided. Contact with the eyes, mucous membranes, or rashes should be avoided. Bandaging should not be done tightly, and inhalation of the product must be prevented.

Patients should be instructed to discontinue use and seek medical advice if they experience skin reactions such as redness, itching, rash, excessive irritation, burning sensation, swelling, or blistering. Additionally, if conditions worsen, symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days, medical consultation is advised.

For individuals who are pregnant or breastfeeding, it is recommended to consult a healthcare professional before use. This product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center should be made.

Side Effects

Patients should discontinue use and consult a healthcare professional if they experience skin reactions, including but not limited to redness, itching, rash, excessive irritation, burning sensation, swelling, or blistering. Additionally, if any underlying conditions worsen or if symptoms persist for more than 7 days, medical advice should be sought. It is also advised that patients seek medical attention if symptoms resolve and then recur within a few days.

Furthermore, individuals with a known allergy to aspirin or salicylates are cautioned to consult a doctor prior to use to mitigate the risk of adverse reactions.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salonpas Pain Relieving Jet (menthol, methyl salicylate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents aged 12 years and older, the recommended application is to the affected area not more than 3 to 4 times daily.

It is important to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure the safety of both the mother and the developing fetus.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. No non-teratogenic effects have been provided in the insert. Additionally, there is no information available regarding nonclinical toxicology or animal pharmacology and toxicology in the insert.

Postmarketing Experience

Postmarketing experience has identified skin reactions as potential adverse reactions. These reactions include redness, itching, rash, excessive irritation, burning sensation, swelling, and blistering. These events have been reported voluntarily or through surveillance programs.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to instruct patients not to use the product on wounds or damaged skin, and to avoid using it in conjunction with a heating pad.

Patients should be informed that they must not use the product if they are allergic to any of its ingredients. They should be counseled to stop using the product and consult a doctor if they experience any skin reactions, including redness, itching, rash, excessive irritation, burning sensation, swelling, or blistering. Additionally, patients should be advised to discontinue use and seek medical advice if their condition worsens or if symptoms persist for more than 7 days. If symptoms resolve and then recur within a few days, patients should also be instructed to stop use and consult a healthcare professional.

When using the product, patients should be reminded to follow the directions carefully. They should avoid contact with the eyes, mucous membranes, or rashes, and should not bandage the area tightly. Inhalation of the product should be avoided. For patients with a history of allergic reactions to aspirin or salicylates, it is essential to recommend consulting a doctor prior to use.

Storage and Handling

The product is supplied in a container that is designed to maintain its integrity under normal handling conditions. It is essential to avoid storing the product in direct sunlight and heat, as these conditions may compromise its effectiveness. Additionally, the product should be kept away from fire or flame, and it is crucial not to use it in areas where sparks may occur.

For safety reasons, the product must not be used in confined spaces. The container is under pressure; therefore, it should not be punctured or incinerated. Exposure to temperatures exceeding 120 degrees Fahrenheit (48 degrees Celsius) must be strictly avoided to ensure the product remains safe and effective. Proper storage and handling are vital to maintaining the quality and safety of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salonpas Pain Relieving Jet, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)